Table 4:
Harm reduction, risk behavior, and substance use at baseline (full analysis set)
| Harm reduction type of participation |
CT participants (n =259 ), no. (%)* |
|---|---|
| Supervised injection site | |
| Yes | 29 (11.6) |
| No | 220 (88.4) |
| Missing | 10 |
| Rehabilitation program | |
| Yes | 46 (18.5) |
| No | 203 (81.5) |
| Missing | 10 |
| Needle exchange program | |
| Yes | 89 (35.5) |
| No | 162 (64.5) |
| Missing | 8 |
| Drug paraphernalia exchange program | |
| Yes | 64 (25.6) |
| No | 186 (74.4) |
| Missing | 9 |
| Opioid agonist therapy | |
| Yes | 134 (53.4) |
| No | 117 (46.6) |
| Missing | 8 |
| Risk behaviour | |
| Reported tattoos or piercings | |
| Yes | 189 (74.4) |
| No | 65 (25.6) |
| Missing | 5 |
| Exchanged sex for money or other reasons | |
| Yes | 40 (16.3) |
| No | 205 (83.7) |
| Missing or unknown | 14 |
| Time since last injection for PWID participants, d, mean (SD) | 117.3 (160.7) |
| Unprotected sexual partners in past 3 mo, mean (SD) | 4.3 (3.4) |
| Brief Addiction Monitor | |
| Overall, mean (SD) | 2.4 (1.4) |
| Use subscale, mean (SD) | 3.2 (3.0) |
| Risk factors subscale, mean (SD) | 11.2 (5.1) |
| Protective factors subscale, mean (SD) | 9.1 (5.1) |
* Unless otherwise indicated
CT = Core transmitter; PWID = People who inject drugs